AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2013

Dec 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-12-04

Reporting Person: Tessier-Lavigne Marc (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-04	Common Stock (right to buy)	$18.01	A	10750	Acquired	2023-12-04	Common Stock (10750)	Direct

Footnotes

F1: This option was granted on December 4, 2013. The shares underlying this option vest as to 100% of the underlying shares on December 4, 2014.